Search for: "Tom Lamb"
Results 281 - 300
of 1,045
Sorted by Relevance
|
Sort by Date
24 Apr 2014, 12:30 pm
We will continue to monitor this emerging drug safety issue concerning heart failure in patients using Onglyza or Kombiglyze for type 2 diabetes treatment. ______________________________________________________________________________ DrugInjuryLaw.com: Current Legal And Medical Information About Prescription Drug Side Effects (All website content by attorney Tom Lamb) Drug Injury Case Evaluation - Free & Confidential (Legal case review done by attorney… [read post]
20 Mar 2020, 9:45 am
(Case review is done by attorney Tom Lamb) [read post]
29 Dec 2011, 11:02 am
Three More Lawsuits (Boles, Jellema, and Spano) Set For Trial, And A Special Master Appointed To Conduct Settlement Talks (Posted by Tom Lamb at DrugInjuryWatch.com) There are currently more than 900 Fosamax lawsuits pending against defendant Merck Sharp & Dohme Corp. [read post]
27 Aug 2012, 2:58 pm
Increasing Safety Concerns About Novartis Drug Gilenya Are Primarily Cardiovascular Side Effects And Unexplained Death (Posted by Tom Lamb at DrugInjuryWatch.com) In August 2012 Health Canada issued the latest drug safety alert concerning Gilenya (fingolimod), which is is a new kind of immunosuppressant drug that has found a role as a treatment for multiple sclerosis (MS) after failing in clinical trials as a drug to prevent rejection of transplanted kidneys. [read post]
23 Jun 2008, 11:55 am
FDA Statement Suggests Actavis Will Be Held Accountable For The Defective Digitek Pills, And Mylan Maintains That This Is Not My(lan) Problem (Posted by Tom Lamb at DrugInjuryWatch.com) When considering where things stand with the Digitek recall, there are a few items that seem noteworthy for various reasons. [read post]
24 Oct 2012, 10:02 am
Defendants Had Sought To Keep Sealed Some Documents That Show NuvaRing Estrogen Levels Were Apparently Concealed Or Misrepresented By Organon (Posted by Tom Lamb at DrugInjuryWatch.com) ______________________________________________________________________________ UPDATE: A similar Order was issued on October 25, 2012 in the federal court NuvaRing MDL by U.S. [read post]
5 Nov 2007, 9:29 am
Market Withdrawal Or Recall Of Trasylol Seems Possible As Bayer Waits For Final Data From Halted BART Study (Posted by Tom Lamb at DrugInjuryWatch.com) On November 5, 2007 the FDA announced and Health Canada announced that sales of Bayer AG' s anti-bleeding drug Trasylol (aprotinin) would be suspended temporarily in the U.S. and Canada while investigations continued about whether Trayslol is linked to a higher risk of death than competing heart surgery drugs. [read post]
26 Nov 2007, 3:06 pm
November 2007 Advisory Panel Meeting To Consider Safety of These Glaxo Drugs As Well As Novartis' Foradil (Posted by Tom Lamb at DrugInjuryWatch.com) An October 24, 2007 FDA staff report about Serevent (SUBJECT: 1-year Post-Pediatric Exclusivity Postmarketing Adverse Event Review) concluded that this inhaled beta-2 agonist asthma drugs as well as Advair "may have an unfavorable risk-benefit ratio" for children's asthma. [read post]
23 Nov 2011, 1:13 pm
Analysis Of PALLAS Study Data Shows Two-Times Increased Risk Of Death, Stroke, And Heart Attack (Posted by Tom Lamb at DrugInjuryWatch.com) ______________________________________________________________________________ UPDATE: FDA Drug Safety Communication: Review update of Multaq (dronedarone) and increased risk of death and serious cardiovascular adverse events Safety Announcement [12-19-2011] The U.S. [read post]
12 Jul 2011, 2:13 pm
EMA And FDA Already Had Sanofi Issue A "Dear Doctor" Letter About Liver Failure In January 2011 (Posted by Tom Lamb at DrugInjuryWatch.com) ______________________________________________________________________________ UPDATE: The FDA announced on July 21, 2011 that it is reviewing data from the PALLAS study which was stopped early after the data monitoring committee found a two-fold increase in death, as well as two-fold increases in stroke and hospitalization… [read post]
19 Nov 2010, 11:40 am
Plaintiff Alleges Novartis Hid Risks Of Osteonecrosis Jaw-Injury From Rita Fussman And Her Doctors (Posted by Tom Lamb at DrugInjuryWatch.com) _____________________________________________________________________ UPDATE: A federal court jury in Winston-Salem, NC has decided that Novartis should pay $12.8 million to the Estate of Rita Fussman because the drug company failed to disclose to Fussman and her doctor possible serious side effects associated… [read post]
13 Apr 2009, 9:58 am
Covers Bowel Cleansing Agents Visicol and OsmoPrep, As Well As Methadone Overdoses, Ethex Generic Drug Recall, And Medication Errors (Posted by Tom Lamb at DrugInjuryWatch.com) The FDA's Patient Safety News (PSN) is a series of monthly video news shows intended primarily for doctors and other health care professionals. [read post]
23 Feb 2011, 2:48 pm
Long-Term Bisphosphonate Use Linked To Subtrochanteric And Femoral Shaft Fractures, Also Called Femur Fractures (Posted by Tom Lamb at DrugInjuryWatch.com) An article published in the February 23, 2011 edition of the medical journal JAMA (Journal of the American Medical Association) reports on research finding that older women who used Fosamax, Boniva, Reclast, or other bisphosphonate drugs had a significant increased risk of suffering leg fractures involving their thigh… [read post]
25 Apr 2011, 1:08 pm
Just As It Did In 2010 Label Change, Bayer Contends New Medical Studies Are Less Reliable Than Other VTE Evidence (Posted by Tom Lamb at DrugInjuryWatch.com) _____________________________________________________________________ UPDATE: FDA Drug Safety Communication: Safety Review of possible increased risk of blood clots with birth control pills containing drospirenone [May 31, 2011]... [read post]
22 Dec 2008, 11:03 pm
Two December 2008 Medical Journal Articles Examine Prescription Drug Hepatotoxicity And Reports Of Liver Damage Associated With Ketek (Posted by Tom Lamb at DrugInjuryWatch.com) Antibiotics cause drug-induced liver injury (DILI) more often than other prescription drugs according to a recent medical journal article, "Causes, Clinical Features, and Outcomes From a Prospective Study of Drug-Induced Liver Injury in the United States", which appeared in the December 2008… [read post]
18 Aug 2009, 11:32 am
Recent Studies Find That New Progestin Drospirenone Has 1.7 Times Increased Risk Of Developing Blood Clots Compared To Levonorgestrel (Posted by Tom Lamb at DrugInjuryWatch.com) Let's start with an August 13, 2009 MedPage Today article, "Thrombosis Risk with OCs Depends on Progestogen", from which we get this concise summary of the issue from Nick Dunn, MD, of the University of Southampton: All of the more recent progestogens, possibly except norgestimate, now… [read post]
28 Jun 2012, 2:45 pm
Medical Journal Article Reports Pradaxa-Induced Rectal Bleeding And Hemostatic Disorder In Two Elderly Patients (Posted by Tom Lamb at DrugInjuryWatch.com) On May 31, 2012 the Institute for Safe Medication Practices (ISMP) released its 2011 Annual Report Issue (PDF) which included new data for the second half of 2011 found in the FDA Adverse Event Reporting System (AERS), which consists of serious drug side effects information taken from FDA MedWatch reports. [read post]
16 Sep 2010, 2:36 pm
FDA Considering Issue Due To September 2010 American Society of Bone And Mineral Research Report About Bisphosphonate Side Effects (Posted by Tom Lamb at DrugInjuryWatch.com) _____________________________________________________________________ UPDATE: FDA Drug Safety Communication: Safety update for osteoporosis drugs, bisphosphonates, and atypical fractures Safety Announcement [10-13-2010] The U.S. [read post]
23 Mar 2009, 11:50 am
Newly Released FDA Report Indicates Medtronic Had First Reports Of Lead Wire Problems In Late 2004 (Posted by Tom Lamb at DrugInjuryWatch.com) A March 14, 2009 New York Times (NYT) article, "Medtronic Links Device for Heart to 13 Deaths", by reporter Barry Meier gave us the latest developments regarding the problems that gave rise to the October 2007 recall of Sprint Fidelis lead wires used in defibrillators. [read post]
28 Jun 2012, 2:45 pm
Medical Journal Article Reports Pradaxa-Induced Rectal Bleeding And Hemostatic Disorder In Two Elderly Patients (Posted by Tom Lamb at DrugInjuryWatch.com) On May 31, 2012 the Institute for Safe Medication Practices (ISMP) released its 2011 Annual Report Issue (PDF) which included new data for the second half of 2011 found in the FDA Adverse Event Reporting System (AERS), which consists of serious drug side effects information taken from FDA MedWatch reports. [read post]
